The spectra with its high power output and variety of dye hand pieces from lutronic has become a gold standard for removing tattoos.
Lutronic spectra laser tattoo removal.
Our patients are very happy with their results.
Tattoo removal with the lutronic spectra laser in recent years tattoos have become more prevalent and vastly more colorful than ever before.
Removal of tattoos depends on the principle of selective photothermolysis.
Additionally its two dye.
Lutronic spectra xt carbon laser peel or hollywood peel duration.
Spectra is the first q switched nd yag laser cleared for the treatment of melasma.
The q switched laser is the most commonly used for tattoo removal.
Hands down it is the best laser system when it comes to tattoo removal before the advent of the medical laser common techniques included cryosurgery dermabrasion or excision.
Treatments for melasma tattoo removal non ablative resurfacing as well as pigmented lesions.
Spectra xt is the latest new cutting edge device from lutronic corporation.
The lower absorption characteristics of.
Spectra is clearly the laser of choice for tattoos.
Tattoo removal using spectra laser los angeles skin perfect brothers duration.
Intelligently designed with the provider in mind.
In addition to the hollywood laser peel no downtime skin brightening treatments spectra offers the best in class tattoo removal with superior color coverage and lutronic continually expands its treatment applications.
Simple two tone tattoos have been replaced with professional multi hued tattoos.
Modulation of treatment parameters allows users to customise treatment based on the condition and skin type of the individual patient to maximise results as well as manage.
When the proper wavelength is applied the ink absorbs the energy preferentially causing it to.
Veins capillaries.
The spectra xt is called the extended platform because of its widely extended clinical indications and applications as compared to previous similar devices currently on the market.
July 09 2019 globe newswire lutronic vision lutronic or the company a wholly owned subsidiary of lutronic corporation today announced that it will present clinical trial data at the 19theuropean society of retina specialists euretina congress to be held at the palais des congres in paris france from september 5 8 2019.